All patients had IUGR (birth weight ranging from -2.2 to -2.9 SD) and postnatally substantially reduced height (range -3.9 to -5.4 SD) with disproportionate microcephaly (range -6.5 to -8.3 SD). Growth parameters were therefore consistent with microcephalic primordial dwarfism, particularly with that seen within the primary microcephaly-Seckel syndrome spectrum S1
. In addition, P1 had two siblings with IUGR, microcephaly and facial features consistent with Seckel syndrome, both of whom died in early infancy as a result of respiratory failure. The clinical features of these siblings have been previously reported S2 ; however DNA was not available to confirm the presence of TRAIP mutations in these two siblings.
All three individuals had similar phenotypic features with long narrow faces, micrognathia and prominent ears. P1 and P2 additionally had scaphocephaly. Mild-moderate developmental delay was present in all. In P2 and P3, neuroimaging demonstrated reduced cerebral cortical size, without thickening of the cortex, consistent with 'microcephaly with simplified gyri' in P2 and P3. In P1, a small cyst between the anterior and posterior pituitary and a slightly enlarged ventricular system were noted.
P1 and P2 experienced frequent lower respiratory tract infections. These required multiple intensive care admissions for P2, with respiratory syncytial infection specifically identified in one such admission. P1 and P2 both had chronic chest X-ray changes; chest CT showing atelectasis with mediastinal shift in P1. Medical management of P2 included prophylactic antibiotics. Respiratory care of P1 included regular chest physiotherapy, inhaled corticosteroid treatment and prophylactic antibiotics. This patient passed away secondary to acute respiratory failure aged 8 years. A diagnosis of asthma has been made for P3 who also has a history of recurrent urinary tract infections. Aside from a mild lymphopenia, not thought to be of clinical significance in P2, no evidence of immunodeficiency was detected in any of the patients. All patients had normal immunoglobulin levels.
Karyotypes from P1-P3 were reported as normal. A trial of GH in P1 did not lead to increased growth velocity. 
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